162 related articles for article (PubMed ID: 11316571)
1. Standardization of prostate brachytherapy treatment plans.
Ove R; Wallner K; Badiozamani K; Korjsseon T; Sutlief S
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):257-63. PubMed ID: 11316571
[TBL] [Abstract][Full Text] [Related]
2. Treatment margins for prostate brachytherapy.
Han B; Wallner K; Aggarwal S; Armstrong J; Sutlief S
Semin Urol Oncol; 2000 May; 18(2):137-41. PubMed ID: 10875455
[TBL] [Abstract][Full Text] [Related]
3. Modification of prostate implants based on postimplant treatment margin assessment.
Mueller A; Wallner K; Merrick G; Courveau J; Sutlief S; Butler W; Gong L; Cho P
Med Phys; 2002 Dec; 29(12):2782-7. PubMed ID: 12512711
[TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy with oblique needles to treat large glands and overcome pubic arch interference.
Ryu B; Bax J; Edirisinge C; Lewis C; Chen J; D'Souza D; Fenster A; Wong E
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1463-72. PubMed ID: 22270172
[TBL] [Abstract][Full Text] [Related]
5. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
6. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
7. Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer.
Polders DL; Steggerda M; van Herk M; Nichol K; Witteveen T; Moonen L; Nijkamp J; van der Heide UA
Acta Oncol; 2015 Jun; 54(6):839-46. PubMed ID: 25591817
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-based treatment planning for prostate brachytherapy.
Albert JM; Swanson DA; Pugh TJ; Zhang M; Bruno TL; Kudchadker RJ; Frank SJ
Brachytherapy; 2013; 12(1):30-7. PubMed ID: 22727474
[TBL] [Abstract][Full Text] [Related]
10. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
[TBL] [Abstract][Full Text] [Related]
11. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
12. MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.
Hanania AN; Kudchadker RJ; Bruno TL; Tang C; Anscher MS; Frank SJ
Brachytherapy; 2020; 19(1):38-42. PubMed ID: 31812590
[TBL] [Abstract][Full Text] [Related]
13. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
14. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
[TBL] [Abstract][Full Text] [Related]
15. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
16. CT-based dosimetry for transperineal I-125 prostate brachytherapy.
Willins J; Wallner K
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):347-53. PubMed ID: 9308938
[TBL] [Abstract][Full Text] [Related]
17. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
18. Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.
Batchelar D; Gaztañaga M; Schmid M; Araujo C; Bachand F; Crook J
Brachytherapy; 2014; 13(1):75-9. PubMed ID: 24080299
[TBL] [Abstract][Full Text] [Related]
19. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
Hsu IC; Lessard E; Weinberg V; Pouliot J
Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
